Prestige Consumer Healthcare Inc. (PBH) Financials

PBH Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 4.6 billion 2.7 billion
March 31, 2026 3.5 billion 1.7 billion
Dec. 31, 2025 3.5 billion 1.7 billion
Sept. 30, 2025 3.4 billion 1.6 billion

PBH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 67.1 million 4.0 million
March 31, 2026 37.6 million 2.6 million
Dec. 31, 2025 75.3 million 2.7 million
Sept. 30, 2025 55.4 million 1.8 million

PBH Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 29.2 million
March 31, 2026 53.9 million
Dec. 31, 2025 46.7 million
Sept. 30, 2025 42.2 million

PBH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 89.1 million 2.0 billion 46.1 million
March 31, 2026 63.9 million 994.0 million 48.5 million
Dec. 31, 2025 62.4 million 1.0 billion 45.7 million
Sept. 30, 2025 119.1 million 993.1 million 47.9 million

PBH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 47.6 million
March 31, 2026 47.7 million
Dec. 31, 2025 48.1 million
Sept. 30, 2025 49.3 million

PBH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3.7 million - 78.0 million 34.7 million
March 31, 2026 5.2 million - 65.4 million 35.1 million
Dec. 31, 2025 3.0 million - 69.7 million 40.1 million
Sept. 30, 2025 2.1 million - 66.7 million 38.7 million

PBH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 265.7 million 129.5 million
March 31, 2026 281.6 million 140.8 million
Dec. 31, 2025 283.4 million 126.1 million
Sept. 30, 2025 274.1 million 120.0 million

PBH Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PBH

Price: $49.20

52 week price:
42.62
89.37

Payout Ratio Range:
79.84%
517.23%

Earnings Per Share: 3.57 USD

P/E Ratio: 14.64

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 211300

Ebitda: 92.0 million

Market Capitalization: 2.2 billion

Links: